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plexes and inhibition of CDK protein kinase activity. TheHarvard Medical School
Kip/Cip proteinscan inhibit each of the cyclin±CDK com-Boston, Massachusetts, 02115
plexes essential for G1 progression and S phase entry.§Hematology Division
The promiscuous CDK-inhibitory activity of p21, p27,Department of Medicine
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Apart from their homologous CDK-inhibitory domain,University of Washington
the Kip/Cip proteins have divergent structural and func-Seattle, Washington 98195
tional properties, which suggests that they might each#Howard Hughes Medical Institute
have unique biological activities. p21, p27, and p57 areJohns Hopkins Oncology Center
most divergent in their carboxy-terminal halves. It isBaltimore, Maryland 21231
through this portion of the protein that p21 directly binds
to the replication protein, proliferating cell nuclear anti-
gen (PCNA), and thereby inhibits its replicative activitySummary
(Flores-Rozas et al., 1994; Waga et al., 1994; Luo et
al., 1995). In fact, the majority of cyclin±CDK moleculesTargeted disruption of the murine p27Kip1 gene caused
in proliferating, nontransformed cells are assembled
a gene dose±dependent increase in animal size with-
into heteromeric complexes containing stoichiometric
out other gross morphologic abnormalities. All tissues
amounts of both p21 and PCNA (Xiong et al., 1993b).were enlarged and contained more cells, although en-
Neither p27 nor p57 binds to PCNA (Luo et al., 1995);docrine abnormalities were not evident. Thymic hyper-
what proteins, if any, bind to their carboxy-terminal do-
plasia was associated with increased T lymphocyte
mains remains to be determined.
proliferation, and T cells showed enhanced IL-2 re-
In addition to their structural differences, the Kip/Cip
sponsiveness in vitro. Thus, p27 deficiency may cause
inhibitors can also be distinguished by their unique re-
a cell-autonomous defect resulting in enhanced prolif- sponses to different mitogenic and anti-mitogenic sig-
eration in response to mitogens. In the spleen, the nals. Various physiological states of cell cycle arrest are
absence of p27 selectively enhanced proliferation of associated with elevated amounts of CDK inhibitors. For
hematopoietic progenitor cells. p27 deletion, like dele- instance, p21 expression is increased in a p53-depen-
tion of theRb gene, uniquely caused neoplastic growth dent manner in cells containing damaged DNAand inde-
of the pituitary pars intermedia, suggesting that p27 pendently of p53 in postmitotic, terminally differentiated
and Rb function in the same regulatory pathway. The cells (El-Diery et al., 1993; Deng et al., 1995; Brugarolas
absence of p27 also caused an ovulatory defect and et al., 1995; Halevy et al., 1995; Parker et al., 1995). p27
female sterility. Maturation of secondary ovarian folli- expression, on the other hand, primarily increases in
cles into corpora lutea, which express high levels of response to extracellular anti-proliferative signals. Nor-
p27, was markedly impaired. mal cells grown to high cell density or deprived of serum
mitogens undergo cell cycle arrest and express elevated
Introduction levels of p27 protein (Firpo et al., 1994; Nourse et al.,
1994; Coats et al., 1996). Moreover, cells exposed to
p27Kip1 is one member of a new class of regulatory pro- anti-mitogenic factors like cAMP and rapamycin also
teins that control cell cycle progression by binding to express elevated levels of p27 (Kato et al., 1994; Nourse
and inactivating cyclin±cyclin-dependent kinase (CDK) et al., 1994), and p27 cooperates with p15 (an INK4
complexes (reviewed by Roberts et al., 1994; Sherr and family member) to cause G1 arrest in cells treated with
Roberts, 1995). p27 was initially discovered as a CDK- transforming growth factor b (Reynisdottir et al., 1995).
inhibitory activity induced by extracellular anti-mito- Thus, p27 might be an essential element in pathways
genic signals (Koff et al., 1993; Polyak et al., 1994a; Firpo that connect mitogenic signals to the cell cycle at the
et al., 1994; Slingerland et al., 1994) and was purified and G1 restriction point. Indeed, cyclin±CDK complexes are
catalytically inactive and quantitatively associated withultimately cloned by virtue of its ability to bind directly
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Figure 1. Targeted Disruption of the p27Kip1
Gene
(A) Diagrams of the murine p27Kip1 gene (WT),
the targeting vector pKNT, and the predicted
recombinant allele (knockout [KO]). Shown
are the genomic DNA regions used as probes
to identify homologous recombinants be-
tween pKNT and the p27Kip1 gene. Also indi-
cated are the sites of PCR primers used to
distinguish the wild-type and disrupted p27
genes in ES cells and in DNA isolated from
mice.
(B) Southern blots of ES cells containing a
targeted disruption of the p27Kip1 gene. Geno-
mic DNA was digested with EcoRV plus XbaI
and probed with the genomic DNA fragments
indicated in (A).
(C) PCR analyses of genomic DNA from
p271/1, p271/2, and p272/2 mice. The null al-
lele, N, and wild-type allele, W, are amplified
using primers N1 plus K3 and K5 plus K3,
respectively. Also shown is an immunoblot of
protein extracted from pituitaries of control,
p271/2, and p272/2 mice.
p27 in cells deprived of serum mitogens. Furthermore, Growth and Viability of p27 Knockout Mice
Of the first 100 F2 progeny, 27 were p271/1, 49 weremitogen-starved fibroblasts cannot efficiently arrest at
the G1 restriction point if p27 expression is blocked with p271/2, and 24 were p272/2. This was consistent with a
simple Mendelian pattern of inheritance and suggestedp27 antisense oligonucleotides (Coats et al., 1996). To
gain further insights into p27 function, we have used that p27 deficiency did not result in significant mortality
during embyrogenesis or fetal development. A cohortgene targeting to construct mice with a homozygous
deletion of the p27 gene. of 90 consecutive F2 generation p27 knockout, hemizy-
gous, and control mice (all 129/Sv 3 C57/B6J hybrids)
have been observed to 9 months of age. A single knock-
Results out mouse died from an invasive high grade thymic lym-
phoma at 6 months of age, but otherwise no fatalities
Targeted Disruption of the p27Kip1 Gene have occurred. By this measure, p27-deficient mice
The p27 gene in mouse and humans comprises two were fully viable.
coding exons; there is also a third noncoding exon 39 F2 generation p272/2 mice were significantly heavier
to the translation stop codon (Pietenpol et al., 1995). than control littermates, and p27 heterozygotes were
The vector used for targeted disruption of the p27 gene, intermediate in size (Figures 2A, 2C, and 2D). The weight
pKNT, contained 7 kb of genomic DNA 59 to exon 1 difference was slightly more pronounced in females and
and 2 kb of DNA 39 to exon 2 (Figure 1A). Homologous was roughly equivalent in inbred (129/Sv) and hybrid
recombination between the targeting vector and the genetic backgrounds (data not shown). The weight dif-
chromosome should replace the entire p27 coding re- ference was not evident at birth, became significant
gion with the pgk±neo marker. Using polymerase chain between 2 and 3 weeks of age, was maximal by 10
reaction (PCR) to detect the presence of a genomic weeks of age, and was maintained throughout adult-
fragment unique to the predicted recombinant, it was hood. (Figures 2C and 2D).
shown that 15% of mouse embryonic stem (ES) cell Apart from their increased size, p27-deficient mice
clones had undergone a homologous recombination were morphologically normal. At necropsy the mice did
event between pKNT and the chromosomal p27 gene. not have a disproportionate amount of body fat. The
Genomic blots using probes external to the targeting increased weight of the p272/2 mice was, at least in
construct confirmed that both the 59 and 39 ends had part, attributable to an enlargement of all internal organs
recombined correctly (Figure 1B). Microinjection of C57/ (Figure 2B). Whereas most organs were increased in
BL blastocysts with p271/2 ES cells produced multiple proportion to overall body weight, the thymus, spleen,
chimeric males, and transmission through the germline and pituitary were disproportionately enlarged (see be-
low). Thymic and splenic enlargement were evident bywas demonstrated for chimeras derived from three ES
cell clones. F1 generation p27 heterozygotes were in- 4 weeks of age, but gross hyperplasia of the pituitary
was not evident in p272/2 mice until 8±10 weeks of age.terbred to produce F2 generation p27 nullizygous mice
(Figure 1C). The complete absence of p27 or truncated The possibility of an endocrine contribution to the
increased size of p27-deficient mice was evaluated byforms of the protein was confirmed on immunoblots, and
the levels appeared intermediate in p27 heterozygotes measuring serum levels of growth hormone (GH) and
insulin-like growth factor 1 (IGF-1), the major hormonal(Figure 1D).
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Figure 2. Increased Growth of p27-Deficient Mice
(A) Photograph of a p272/2 mouse and a control littermate at 6 weeks of age.
(B) Mean and 95% confidence interval of organ weights from 20 control and p272/2 mice at 6±7 weeks of age. Plotted is percent increase in
weight in knockout mice compared with control mice.
(C) Mean and 95% confidence interval of weights of 30 control, p271/2, and p272/2 female mice as a function of age. Inset shows weights of
a separate group of 20 male plus female mice weighed at birth and at 10 days. Data from 21 days is the mean of the results from the first
group.
(D) Same as (C), but data were obtained from male mice.
determinants of postnatal growth. The mean serum lev- rare in the proliferating basal region (data not shown).
Tissues from p272/2 mice did not exhibit specific immu-els of GH, IGF-1, and IGF-1-binding protein in four
knockout males at either 6 or 12 weeks of age were not nostaining (data not shown; see Figure 7D).
The majority of tissues (listed in Experimental Proce-significantly different from levels in control littermates
(data not shown). dures) obtained from 6-week-old p272/2 mice displayed
normal histologic characteristics. No cellular hypertro-
phy was observed, in contrast with what has been re-General Anatomic and Histologic Features
The in vivo distribution of p27 protein in mice ranging ported in giant mice expressing a GH transgene. Only
the pituitary and ovary were remarkable, and the histo-in ages from 4±18 weeks was evaluated by immunohis-
tochemistry. Virtually all tissues in control mice ex- logic features of those organs are described in detail
below. We also noted a subtle disorganization of thepressed p27, its subcellular localization was almost ex-
clusively nuclear, and immunoblots confirmed its retina, characterized by loss of the normally sharp
boundary between the inner and outer nuclear layers.ubiquitous pattern of expression (data not shown). As
a general rule, p27 protein expression was restricted to Hyperplasia may result in increased cell density (and
therefore a decrease in average cell size) independentnonproliferating cells. In the intestine, for example, p27-
positive cells were localized to the quiescent cells occu- of overall organ size. Cell density determinations were
obtained from both the liver and the brain by countingpying the mid and apical regions of the villi and were
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fresh blood, hemosiderin deposits, and the brown pig-Table 1. Hepatocyte and Neuronal Cell Counts
mentation noted in gross specimens. Even in younger
Relative
mice, no areas of normal pars intermedia surroundedWild-Type p272/2 Increase (%)
the abnormal tissue, suggesting a progressive nonfocal
Liver (n 5 6) 133 (16) 163 (14) 23
process. Together these features indicate an adenoma-
Brain (n 5 3) tous, neoplastic transformation of the pars intermedia
Cerebral cortex 82 (2.1) 108 (2.0) 32 cells. At 9 months of age, there has been no indication
Hippocampus 111 (3.5) 147 (2.1) 32 of early mortality in the 129/Sv 3 C57/B6J hybrids, but
Habenular nucleus 152 (2.1) 198 (8.6) 30 the majority of inbred (129/Sv) animals have died with
The number of hepatocyte and neuronal cells per unit volume massively enlarged pituitary tumors.
counted in separate experiments. Group means (and standard devi- Transmission electron microscopy and immunocyto-
ations) represent the number (n) of animals indicated. The relative chemistry together confirmed that the adenomatous
increase in hepatocyte and neuronal cell density in the 2/2 mice
cells arose from the pars intermedia. Electron micros-was statistically significant (p , 0.05).
copy revealed normal cytoarchitectural features of the
pars nervosa and pars distalis in knockout mice. The
cells comprising the abnormal tissue in knockout mice
nuclei from fixed volume of tissue from anatomically most closely resembled pars intermedia from normal
identical regions.Hepatocyte cell density was increased mice (Figure4). No ultrastructural features characteristic
an average of 23%, and neuronal cell density in each of normal pars distalis cells were present in the tumor
of three anatomically distinct forebrain regions was in- tissue. Both control and knockout cells shared the same
creased by approximately 30% in p27 knockout mice uniformly oval cytoplasm filled with low to moderately
(Table 1). No other abnormalities in central nervous sys- electron dense secretory vesicles and mitochondria, all
tem neuroanatomy were found. characteristics of pars intermedia cells. However, the
nuclei of knockout cells possessed more condensed
chromatin and had a more bizarre configuration thanPituitary Adenomas
control cells. The abnormal tissue stained positively forAll p27 knockout mice over the age of 10 weeks (15 out
a melanocyte-stimulating hormone, b-endorphin, andof 15) developed 2- to 5-fold enlargement of the pituitary
adrenocorticotropic hormone (Figure 3), a triad of pro-(Figures 3A and 3D). Histologic inspection revealed
teins derived from the proopiomelanocortin (POMC)marked expansion of the pars intermedia (Figures 3B
gene product and produced in pars intermedia. Usingand 3E). This often caused compression and displace-
antibodies to the anterior pituitary hormones thyroid-ment of normal-appearing pars nervosa and pars dis-
stimulatinghormone, follicle-stimulatinghormone (FSH),talis, but without direct invasion of the surrounding tis-
luteinizing hormone (LH), prolactin, and GH, identicalsue. The cells had varying degrees of cytoplasmic
patterns of histochemical staining were found in thebasophilia and nuclear atypia. Interstitial hemorrhage
was present in most specimens, resulting in lakes of pars distalis of the control and knockout mice. None of
Figure 3. Pituitary Tumorigenesis in p272/2
Mice
(A and D) Dorsal views of pituitaries of 10-
week-old control (A) and p272/2 mice (D) pho-
tographed in situ. The p27 null mouse pitu-
itary is enlarged and hyperpigmented.
(B and E) Sections of pituitary stained with
hematoxylin and eosin from control (B) and
p272/2 mice (E) at 10 weeks of age (magnifica-
tion, 403). Indicated are the pars distalis (D),
pars intermedia (I), and pars nervosa (N). The
residual pars distalis and pars nervosa in the
p272/2 pituitary are also indicated, as are the
adenomatous cells of the abnormal pars in-
termedia (A) and areas of hemorrhage (h).
(C and F) Histologic sections of control (C)
and p272/2 (F) pituitaries immunostained to
detect expression of the indicated proteins
(magnification, 103).
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Figure 4. Ultrastructural Analysis of Tumor
Cells Identifies Their Origin as the Pituitary
Pars Intermedia
Transmission electron micrographs of pitu-
itary pars distalis (A) (magnification, 11003),
pars nervosa (B), and pars intermedia (C) from
p271/1 mice and the adenomatous tissue
from a p272/2 littermate (D). (B)±(D) are
viewed at 20003 magnification.
these hormones was expressed in cells of the adenoma- was not accompanied by notable histologic abnormali-
ties (Figures 5A and 5B). Figure 5 graphically documentstous tumor tissue (data not shown).
the dramatic increase in thymic cellularity in p272/2
mice, the thymi of which can contain more than 109 cells.Lymphoid Populations
While the disproportionate increase in pituitary sizeseen Despite this approximately 3-fold increase in thenumber
of thymocytes, the development of these cells was re-in p272/2 animals results from progressive neoplastic
growth, thymic and splenic hyperplasia in these animals markably unperturbed. Flow cytometric evaluation re-
Figure 5. Thymic and Splenic Development
in Control and p272/2 Mice
(A) Photographs of thymus and spleen from
control and p27 null mice.
(B) Photomicrographs of control and p272/2
thymus stained with hematoxylin and eosin
(magnification, 153).
(C) Relative distribution of thymocyte subsets
in the 6-week thymus were determined by
staining for expression of the indicated lin-
eage-specific cell surface antigens and sort-
ing cells by flow cytometry. Relative percent-
ages of cells with each cell surface
characteristic are indicated.
(D) Absolute cell numbers (mean and stan-
dard deviation) in control and p272/2 thymus
and spleen.
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Figure 6. Increased Proliferation of p272/2 T
Lymphocytes In Vivo and In Vitro
(A) Increased S phase fraction of p272/2 thy-
moblasts. Representative histograms from
one wild-type and one p272/2 animal are
shown. Similar results were obtained for frac-
tionated CD41, CD81, or CD41CD81 blast
subpopulations.
(B) Increased cyclin E±associated histone H1
kinase activity in p272/2 thymocytes. Results
were quantitated by phosphorimaging, and
mean and standard deviation values from 6
controls and 12 p272/2 samples are shown.
(C) Enhanced mitogenic activation of p272/2
splenic T cells in vitro. Splenic T cells were
stimulated for 48 hr in vitro using plate-bound
anti-CD3 antibodies and IL-2. DNA content
was determined by flow cytometry, and per-
cent values for S/G2/M phase cells are
shown.
(D) Enhanced mitogenic activation of p272/2
thymocytes in vitro. Whole thymocyte prepa-
rations were stimulated using anti-CD3 anti-
bodies and a titration of IL-2 for 48 hr, pulsed
with [3H]thymidine, and harvested 15 hr later
(Appleby et al., 1992). Data shown are means
and standard deviations (for controls) or stan-
dard errors (for p272/2) derived from two wild-
type and four p272/2 mice.
vealed normal proportions of immature CD4282 thymo- could be demonstrated in thymic and splenic T cells.
p272/2 thymoblasts harvested directly from the animalcytes, a population that ordinarily includes the highest
percentage of replicating cells, and of their more mature had an increased percentage of S phase cells and a
3- to 4-fold increase in cyclin E±associated kinase activ-CD4181 progeny (Figure 5A). Moreover, the selective
processes that permit emergence of mature, single-pos- ity when compared with control thymocytes (Figures 6A
and 6B). A similar increase in cyclin E±associated kinaseitive (CD4182 and CD4281) thymocytes, and their export
to peripheral lymphoid organs, appeared grossly intact activity was observed in purified splenic T cells (data not
shown). Increased mitogen responsiveness of p272/2(Figure 5; data not shown). Hence, the absence of p27
results in impressive thymic hyperplasia without imposi- splenic and thymic T cells was also seen in vitro (Figures
6C and 6D). These results are consistent with previoustion of appreciable developmental pathology.
Splenocytes of p272/2 mice were also more abundant experiments implicating p27 in modulating the mito-
genic effect of interleukin-2 (IL-2) (Firpo et al., 1994;than in control mice (Figure 5B), resulting in part from
the increased representation of T lymphocytes (Figure Nourse et al., 1994). TUNEL assays indicated that the
percentage of apoptotic cells was the same in control5B). Indeed, the absolute number of B lymphocytes in
the spleens of these animals, defined as B2201, surface and p272/2 thymocytes (data not shown). Together,
these data suggest that the increased numbers of thy-immunoglobulin±bearing cells, was normal (data not
shown). In addition, a population of large, heteroge- mocytes in p272/2 mice was due to increased cell prolif-
eration rather than diminished cell death.neous, CD32, B2202, GR-12, Mac-12 cells was variably
increased in abundance in the p272/2 spleens (data not
shown). These cells almost certainly include immature Hematopoietic Progenitors
Peripheral blood cell counts of erythrocytes, neutro-hematopoietic progenitors (see below).
A direct effect of p27 deficiency on cell proliferation phils, monocytes, and platelets were normal in the p272/2
Table 2. Hematopoietic Colony Formation
GFU-GM CFU-E CFU-MK BFU-E
Femur
Wild type 25.5 6 1.2 88.0 6 14.7 4.42 6 0.73 2.60 6 143
p27 null 34.2 6 1.4 120.0 6 22.7 4.10 6 0.55 4.61 6 0.94
pa 0.02 0.20 0.50 0.10
Spleen
Wild type 2.90 6 0.61 135 6 16.3 2.58 6 0.24 1.03 6 0.34
p27 null 9.34 6 0.54 440 6 144 7.37 6 0.86 3.11 6 0.36
pa 0.001 0.05 0.05 0.15
Shown are total numbers of colony-forming units (3103) per organ.
aStatistics by Mann±Whitney test.
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Figure 7. Luteal Phase Defect in the p272/2
Ovary
Sections of 10-week-old p27 null ovaries
stained with hematoxylin and eosin (A) (mag-
nification 253) lack corpora lutea (CL), which
are normally found in the control (B). Corpora
lutea appear in p272/2 ovaries (C) following
gonadotropin administration. Corpora lutea
in control ovaries stain intensely for p27 pro-
tein expression (D) ([C] and [D] represent im-
munoperoxidase detection of p27 protein
with methyl green counterstain).
mice compared with age-matched controls. However, to recover of oocytes at 0.5 days postcoitum (dpc). To-
we noted significant increases in thenumbers of multiple gether this implies that loss of p27 causes a relative
types of hematopoietic progenitors. In four separate resistance of the ovary to luteinizing hormones. p27 is
experiments, the number of granulocyte-macrophage highly expressed in the cells of control corpora lutea,
(CFU-GM), early and late erythroid progenitors (BFU-E consistent with a possible role for p27 in granulosa cell
and CFU-E), and megakaryotic progenitors (CFU-MK) luteal differentiation (Figure 7D). Progesterone rose ap-
increased in both the marrow and spleen. The increase propriately starting at day 4.5 in knockouts following
in progenitor levels was more pronounced in the spleen superovulation, demonstrating at least partial function
than the marrow. In the spleen, the increase in CFU- of the artificially induced corpora lutea (data not shown).
GM ranged from 3.2- to 9.4-fold, reaching statistical Superovulation produced numerous (5±20) preimplan-
significance in each of four experiments and in the ag- tation embryos at day 3.5 in each of four p272/2 females
gregate (p < .004). The number of marrow CFU-GM in- paired with knockout males. In fact, transfer of these
creased from 1.3- to 2.0-fold, statistically significant in preimplantation embryos to the uterus of pseudopreg-
the aggregate (p < .004). A representative experiment nant control recipients produced normal-sized litters,
using inbred animals is shown (Table 2). These hemato- excluding the possibility that sterility is due to loss of
poietic progenitor cell increases are consistent with the a circulating fetal factor (e.g., chorionic gonadotropin).
increase in splenic cellularity and suggest that the effect Superovulation was not sufficient to induce successful
of p27 is exerted at an early stage of cell lineage determi- pregnancies in any of a dozen plugged knockout fe-
nation. males (but was successful in three of four controls).
Despite superovulation, gross and histologic inspection
Female Sterility of the uterus showed that no implantation occurred in
Male p272/2 mice sired normal-sized litters, but female the majority of knockout mice. Among three mice that
p272/2 mice did not become pregnant, even when paired showed evidence of uterine implantation, the number of
with control males. The histologic appearance of the sites of implantation was greatly reduced, but appeared
uterus and ovary at ages 3, 6, and 10 weeks of age was histologically normal; both a uterine decidual reaction
normal except for the conspicuous absence of corpora and postimplantation embryos were present. The uter-
lutea in mature knockout females (Figures 7A and 7B). ine environment in p27 null females was inadequate,
Of six knockout breeder pairs checked daily for 1 month, since neither successful ovulation nor implantation was
only two spontaneous copulation plugs were found. Oo- sufficient to produce a successful pregnancy.
cytes were isolated from the oviduct of one of these
females on gestation day 0.5, demonstrating that the
Discussionblock to ovulation was not fully penetrant. The luteal
phase defect in p272/2 females did not appear to be due
Increased Growth of p27-Deficient Miceto lack of circulating gonadotropins or the inability to
p27Kip1 gene dosage determined animal size; p271/2 hem-produce peak levels of these hormones, because aver-
izygotes were intermediate in size between the smallage levels of FSH and LH were comparable in knockouts
p271/1 and large p272/2 homozygotes. Although the p27-at both baseline and post-oopherectomy (data not
deficient animals were considerably heavier than con-shown). However, administration of super-physiologic
trols, they were not obese. Essentially all organs in alevels of gonadotropins (superovulation) consistently in-
p27 nullizygous mouse were at least 20% larger thanduced ovulation, as evidenced by the presence of histo-
logically normal corpora lutea (Figure 7C) and the ability controls. This was caused by increase in cell number,
Cell
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rather than an increase in cell size or the amount of Independent support for a cell cycle defect in p27-
extracellular material. deficient cells emerged from our analysis of cell density
Increased animal size can be associated with endo- in various tissues. In liver and brain, we showed that
crine abnormalities. Gigantism results from the enforced p272/2 cells were smaller than control cells. The smaller
overexpression of either GH (Palmiter et al., 1982) or size of p27-deficient cells is similar to the effect caused
IGF-1 (Mathews et al., 1988). IGF-2 has also been impli- by overexpressing G1 cyclins (Cross, 1988; Ohtsubo
cated as a determinant of animal size, primarily during and Roberts, 1993; Quelle et al., 1993) and may reflect
embryonic growth (DeChiara et al., 1990). The presence altered coupling between cell growth and the cell divi-
of pituitary pathology, and the concomitant defects in sion cycle.
fertility, raised the question of whether hormonal
changes might underlie the increased size of the p27
knockouts. However, the adenomatous cells of the pars Pituitary Tumorigenesis
intermedia did not express GH, norwere there increased By histological, ultrastructural, and immunocytochemi-
numbers of GH-producing cells in the normal-appearing cal criteria, adenomatous growth in the p272/2 mice
pars distalis. In addition, mice lacking p27 had normal was restricted to the melanotrophic cells of the pars
serum levels of both GH and IGF-1, and serum levels of intermedia. Pituitary pathology was grossly evident by
IGF-1-binding protein were within normal limits, arguing 2±3 months of age, but histologic inspection of pituitar-
against a shift in the amount of bound versus free IGF-1. ies from mice as young as 4±6 weeks showed uniform
Nor did the pattern of accelerated growth parallel what pars intermedia hyperplasia. In these young mice, there
has been described for mice overproducing GH, IGF-1, was no evidence of focal lesions surrounded by normal-
or IGF-2. GH and IGF-1 transgenic mice have normal appearing tissue. Thus, not only did the pituitary tumors
birth weights; growth is not accelerated until after 3±4 occur with 100% penetrance, but they appeared to in-
weeks or 6±8 weeks of age, respectively. Mice systemi- volve the entire pars intermedia. This suggested that
cally overproducing IGF-2 are born heavier than con- loss of p27 was sufficient to cause abnormal prolifera-
trols, but increased size is not maintained into adulthood tion and that occurrence of a second genetic event may
(Wolf et al., 1994). In contrast, p272/2 mice are not larger not be required. By 9 months of age, p27 nullizygotes
than controls at birth, but attain an increased size within showed no significant occurrence of other tumors, and
the first 3 weeks of life and are larger as adults. GH, this is consistent with the absence of homozygous p27
IGF-1, and IGF-2 can cause organomegaly (Palmiter et mutations in primary human tumors (Pietenpol et al.,
al., 1983; Mathews et al., 1988; Quaife et al., 1989; Wolf 1995; Ponce-Castenada et al., 1995; Kawamata et al.,
et al., 1994; Ward et al., 1994; Buul-Offers et al., 1995). 1995). However, the dosage effect of p27 gene deletions
However, only selected organs are affected, and this on mouse body size suggests that the hemizygous dele-
contrasts with the generalized organomegaly in the tions of p27 found in human hematopoietic malignancies
p272/2 mouse. In sum, when the pattern and timing of (Pietenpol et al., 1995; Sato et al.,1995) may enhance cell
organ enlargement, the histologic features of affected proliferation and contribute to malignant progression.
organs, and the apparently normal serum hormone lev-
Pituitary tumors inboth mice and humans usually arise
els are all taken into consideration, the overall picture
as adenomas within the pars distalis, and tumors of the
is incompatible with previous descriptions of gigantism
pars intermedia are rare. It is striking that deletions of
due to endocrine effects.
p27 or Rb (retinoblastoma) (Williams et al., 1994; Hu etThe effect of p27 on animal size may be cell autono-
al., 1994) are the only gene defects known that causemous, an idea most consistent with the molecular biol-
pars intermedia tumors, and both do so with almostogy of p27 function (see Introduction). This would repre-
100% penetrance. It is plausible, therefore, that the un-sent an example of a cell-autonomous determinant of
usual pattern of tumor development shared by p27 andsize in multicellular organisms. The absence of p27 may
Rb mutant mice is a consequence of the interaction ofallow continued cell proliferation despite low or absent
these proteins in a common regulatory pathway. p27mitogenic stimuli, the outcome being generalized hyper-
inhibits kinase activity of CDK2±cyclin E/A, CDK4±cyclinplasia and increased body size. Indeed, we have shown
D, and CDK6±cyclin D complexes. All these kinasesboth increased proliferation in vivo and increased mito-
phosphorylate the Rb protein in vitro, and correlationsgen responsiveness in vitro of p272/2 thymic and splenic
have been drawn between their activation and Rb phos-T lymphocytes. One extreme model, which we can ex-
phorylation in vivo. If p27 were the primary regulatorclude, is that loss of p27 caused massive increases in
of Rb phosphorylation in the pars intermedia, then thecell proliferation that were largelybalanced by increased
absence of p27might allowconstitutive hyperphosphor-cell death. This conclusion is based on the fraction of
ylation and inactivation of Rb and transformation of theS phase cells in various tissues measured by fluores-
pars intermedia melanotrophs.cence-activated cell sorter (FACS) analysis and bromo-
Melanotroph proliferation may be primarily underdeoxyuridine (BrdU) staining, combined with the ab-
negative control by the neurotransmitter dopamine. Do-sence of an increased number of apoptotic cells. It is
paminergic innervation coincides with inhibition of mela-more likely, therefore, that p27 deficiency increases cell
notroph proliferation in developing rats, and pharmaco-proliferation to an extent that is concordant with the
logic agonists or antagonists of dopamine inhibit oroverall increase in cell number. The threshold that p27
promote melanotroph proliferation, respectively, both inimposes on CDK activation and cell proliferation appar-
vivo and in vitro (Gary and Chronwall, 1992; Gehlert etently is regulated very tightly. Even a partial decrease
al., 1988; Chronwall et al., 1987). The anti-proliferativein p27 levels appears to increase cell proliferation in vivo,
as evidenced by the increased size of p27 hemizygotes. effect of dopamine may be exerted at a point in the cell
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cycle where both p27 and Rb are required to maintain idea is that p27 deficiency may induce hyperplasia of
the committed progenitor or stem cells for many lin-cell cycle arrest. Alternatively, the loss of p27 may impair
the development or function of the dopaminergic neu- eages and that this is the developmental basis for the
increased overall size of the knockout mice. In fact, werons that innervate the pars intermedia. By either model,
the unique behavior of these cells may be the conse- have observed that the relative increase in hematopoi-
etic progenitor cells in the spleen is greater than thequence of the fact that their proliferation is primarily
determined by removal of an inhibitory signal, whereas relative increase in their differentiated descendants
(e.g., more than a 3-fold increase in splenic CFU-E andthe proliferation of most other cell types is often depen-
dent upon provision of a growth stimulus. CFU-GM, but less than a 2-fold increase in the numbers
of mature cells in the spleen and peripheral blood; Table
2; data not shown). Thus, p27 may have a selectiveFemale Sterility
effect on the self-renewing, mitogen-driven cell cyclesDeletion of p27 caused female specific sterility. Second-
characteristic of stem and some progenitor cells. How-ary ovarian follicles developed, but did not progress to
ever, once cells embark on a program of differentiation,form corpora lutea. Gonadotropin production did not
they often undergo a relatively fixed number of pro-appear tobe impaired, because normalnumbers of FSH-
grammed cell divisions and enter a state of mitogen-and LH-producing cells were visualized by immunohis-
independent cell cycle arrest. Since p27 appears to betochemical staining in the anterior pituitary and both
primarily involved in the cellular response to extracellu-basal and peak serum levels of FSH and LH were normal.
lar mitogens, its absence might have relatively little im-One clue to the origin of the infertility may be that p27
pact during the process of terminal differentiation. Inprotein was highly expressed in corpora lutea of control
this regard, the disproportionate growth of the thymusmice. Thus, p27 deficiency may impart a relative resis-
compared with other tissues in the p272/2 mouse istance to the action of LH on the mature follicle. In accord
interesting, especially in the light of evidence that p27with this idea, exogenous administration of greater than
may have a key role during mitogenic activation of ma-physiological amounts of gonadotropins induced ovula-
ture T lymphocytes by IL-2 (Firpo et al., 1994; Noursetion, differentiation of corpora lutea, and early develop-
et al., 1994). This points out that the distinction betweenment of viable embryos in knockout females. These em-
mitogen-dependent proliferation of progenitor versusbryos implanted but did not develop to term in the
fully differentiated cells must be drawn carefully. p27knockout females, raising the possibility that the ab-
appears to play an ongoing role in some differentiatedsence of p27 caused a second block to development
cells, such as T lymphocytes, which retain the ability tointrinsic to the uterus. In sum, p27-deficient mice have
proliferate in response to mitogenic signals.both ovarian and uterine dysfunction, but it is not yet
known whether these are a direct effect of the absence
Experimental Procedures
of p27 in the reproductive organ.
Production of p27 Null Mice
A 17 kb NotI fragment containing the entire coding region of theProgenitor Cell Hyperplasia
p27 gene was obtained from a mouse 129/Sv l genomic library
p27 is expressed at high levels in nondividing cells, (obtained from Paul Stein) using a p27 cDNA probe. pKNT was
including cells that have become quiescent in response constructed by subcloning a 7 kb XhoI fragment and a 1.8 kb BglII±
EcoRI genomic DNA fragment into the targeting vector pPNT (Tybu-to mitogen depletion and those that have become post-
lewicz et al., 1991). pKNT was linearized with HindIII and transducedmitotic as part of a program of terminal differentiation.
by electroporation into mouse XY AK7 ES cells (courtesy of PhillipeThe phenotype of the p27-deficient mice suggested that
Soriano; Soriano et al., 1991). ES cells were selected in 400 mg/p27 is important for the former response butdispensable
ml G418 and 0.2 mM FIAU. Colonies of ES cells with homologous
for the latter. This is best illustrated and was most care- recombination events were identified by PCR amplification of a 2 kb
fully analyzed in the thymus, where dramatic hyperplasia fragment using a primer derived from p27 genomic DNA sequences
downstream from exon 2 (K2, TTCTTACCGAAAGGGACACTAATC)had no detectable impact on thymic development or
and from the neomycin gene (N1, CCTTCTATGGCCTTCTTGACG).thymocyte differentiation. Each of the normal thymocyte
PCR reactions were performed for 40 cycles (938C for 30 s; 558C±subpopulations were increased in number and in the
578C for 30 s; 658C for 2 min) as previously described (Kogan et al.,correct proportion to one another; there was no evi-
1987). Southern blots using probes external to both the 59 and 39
dence for neoplastic growth or selective expansion of a end of the targeting construct confirmed that a homologous recom-
subset of thymocytes. The spleen in the p27 nullizygous bination occurred in each of the six clones used for blastocyst
injection. p272/1 ES cells were introduced by microinjection into 5mouse was also disproportionately hyperplastic, yet its
dpc C57/B6J mouse embryos. Germline transmission was identifiedhistologic organization appeared normal and cells from
in male chimeras representing three separate ES cell clones. Homo-all hematopoietic lineages were normally represented.
zygous p27 deletions in the F2 generation were confirmed by theHistologic examination suggested that these conclu-
presence of a 0.5 kb PCR fragment unique to the mutant transgene
sions applied without exception to other tissues as well. with primers N1 and K3 (TGGAACCCTGTGCCATCTCTAT) and the
The vast majority of tissues in mice lacking p27Kip1 had absence of the corresponding 0.9 kb fragment unique to the wild-
type allele using primers K3 and K5 (GAGCAGACGCCCAAGAAGC).essentially no pathologic abnormalities, and the p271/2
hemizygotes, apart from their increased size, appeared
Anatomic and Histologic Assessmenttotally normal.
A cohort 30±40 F2 generation hybrids from each genotype (p272/2,In the thymus and spleen, we have shown that the
p272/1, and p271/1) was observed and weighed at regular intervals.
loss of p27 leads to increased numbers of hematopoietic We weighed 6- to 7-week-old mice (both congenic 129/Sv and hy-
progenitor cells. It is difficult to measure accurately pro- brid C57/B6J) at necropsy to confirm the absolute differences in
animal size. Internal organs were weighed, and the following tissuesgenitor or stem cell numbers in other organs, but one
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were fixed in 10% neutral buffered formalin (Sigma): brain, pituitary, isothiocyanate±labeled Lyt-2 (clone CT-CD4) and phycoerythrin-
conjugated L3T4 (clone CT-CD8a) (Caltag Laboratories), respec-eye, lacrimal gland, trachea, esophagus, heart, lung, thymus, axillary
lymph node, liver, stomach, duodenum, colon, kidney, adrenal, pan- tively. Events were collected in list mode files on a FACS-Star flow
cytometer (Beckton Dickinson) and analyzed using Repro-Mac soft-creas, urinary bladder, testis, ovary, uterus, skin, and femur. Tissues
were paraffin embedded, cut in 5 mm sections and stained with ware (True Facts Software).
hematoxylin and eosin. Brains and pituitaries were fixed in 4% para-
formaldehyde for immunoperoxidase staining and cell counts by
first perfusing the animal with PBS and then fixative. Hematopoietic Hematopoietic Progenitor Assays
Femurs, tibiae, and spleens were removed aseptically, marrow cellsdifferential cell counts were obtained from Wright±Giemsa-stained
blood smears and cytospin preparations of marrow and spleen. were flushed into Iscove's modified medium (IMDM) containing 10%
fetal calf serum and single cell suspensions made by aspirating
cells through smaller-gauge needles. Colony-forming assays wereTransmission Electron Microscopy
performed in triplicate as described previously (Broudy et al., 1995).We anesthetized 5-month-old male control and knockout mice, per-
In brief, for CFU-GM and CFU-MK determinations, 1 3 105 marrowfused them with 2% glutaraldehyde, 2% paraformaldehyde in 0.1
or 1 3 106 spleen cells were plated in a 1 ml culture plate in IMDMM phosphate buffer, and postfixed the pituitaries and brains in 2%
containing 15% horse serum, 100 U/ml murine IL-3, 30 ng/ml humanglutaraldehyde, 2% paraformaldehyde in 0.1 M phosphate buffer
IL-11, 1000 U/ml murine TPO, 1% penicillin±streptomycin±fungi-for 4 hr. Tissue was washed three times overnight in 0.2 M cacodyl-
zone, 5 3 1025 M b-mercaptoethanol, 2 U/ml human erythropoietin,ate buffer, fixed in 2% OsO4 for 1 hr, dehydrated in graded ethanol
1.5%pokeweed mitogen-stimulatedmurine spleen cell±conditionedsolutions, immersed in propylene oxide, and embedded in LX-12
medium and were made semisolid with 0.28% agar. Cultures were(Ladd Industries). Parasagittal pituitary sections (60±90 nm) were
incubated for 5 days in a humidified atmosphere containing 5% CO2.cut, mounted onto grids, and counterstained with uranyl acetate
Early erythroid progenitors (BFU-E) were cultured, as described, inand lead citrate. Grid-mounted sections were examined in a JEOL
IMDM supplemented with 30% fetal calf serum, 1% BSA, 5 3 10251200 EX-1 microscope, and fields were photographed at magnifica-
b-mercaptoethanol and made semisolid with 1.4% methylcellulosetions ranging from 20003 to 40003 at 120 kV.
(Kaushansky et al., 1994). Late erythroid progenitors (CFU-E) were
quantified in a plasma clot assay as previously described (BroudyCell Counts from Brain and Liver
et al., 1988). Megakaryocyte colonies containing more than threeCell counts were obtained from hematoxylin±eosin-stained sections
large refractive cells and myeloid and erythroid colonies containingof forebrain from three wild-type and three knockout male mice.
more than 40 cells were enumerated by inverted electron mi-Neurons were counted at 4003 magnification in the following ana-
croscopy.tomic loci: 1 cm diameter column of full-thickness cerebral cortex
located at the junction of anterior corpus callosum and cingulum at
the level of the adjacent habenular nucleus; the habenular nucleus;
Fertility and Endocrine Investigationsthe rostral zone of dentate in hippocampus. Neurons were counted
Breeding capacity was determined with four to six pairs of breedersfrom identically circumscribed volumes on the basis of characteris-
of every genetic combination (2/2, 1/2, and 1/1). Results weretic morphology found on hematoxylin±eosin stain. The average of
confirmed in congenic (129/Sv) mice. Superovulation of 5-week-three separate counts was obtained from each site in each mouse.
old F2 generation hybrid females was performed as described byCounts from both 3-month-old and 5-month-old mice were com-
administering pregnant mare's serum (5 U intraperitoneally; Sigma),bined for analysis, since neurons are already postmitotic at birth
followed by hCG (5 U intraperitoneally) 48 hr later (20.5 dpc). Peptideand their cerebral number is fixed. Separate groups of six p272/2
hormone assays were performedby 125I-RIA using known concentra-and six sex-matched controls were used to measure the density of
tions of hormone for standard curves. Retro-orbital blood was ob-hepatocytes in 0.4 mm hematoxylin±eosin-stained tissue sections
tained under moderate anesthesia provided by halothane inhalationfrom the areas surrounding single hepatic venules. Polaroid photo-
in four p272/2 and four age- and sex-matched controls. GH levelsgraphs were obtained, and the number of hepatocyte nuclei in 12
were determined by RIA (Amersham) in both 6- and 12-week-oldhigh power fields from each animal was counted.
females (four knockout mice and four controls at each age). Like-
wise, serum was obtained for the following assays: IGF-1 and IGF-Antibodies
1-binding ligand, 4-month-old males; FSH and LH, 6- to 8-week-oldAffinity-purified rabbit anti±mouse p27 antibody was courteously
females and 12-week-old females 2 weeks post-oopherectomy.provided by R. Sheaff. Anti-b-FSH and anti-GH antibodies were
obtained from the National Pituitary Agency. Anti-b-LH was a gift
of L. Duhamel. Both anti-prolactin and anti±thyroid-stimulating hor-
Acknowledgmentsmone antibodies were obtained from INCSTAR. Anti±adrenocortico-
tropic hormone, anti±a melanocyte-stimulating hormone, and anti-
We thank Mark Gurian-West, Norma Fox, Nancy Lin, Laura Gatti,b-endorphin antibodies were obtained from BioGenex Labs.
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FSH and LH, and prolactin levels, respectively. L. Duhamel, A. F.plus DAB as a chromogen (Hsu and Soban, 1982). Pituitary sections
Parlow, and the National Pituitary Agency provided pituitary anti-were stained in a similar fashion for the presence of the pituitary
bodies. We also thank Norm Wolf, Mark Groudine, Richard Palmiter,hormones. Deparaffinized sections were blocked for endogenous
and colleagues at the Fred Hutchinson Cancer Research Centerperoxidase in 3% H2O2 for 5 min (for p27) or 30 min (for pituitary
for suggestions during the course of this work and Andy Koff forhormones). Specimens to be stained for the presence of p27 were
discussing results prior to publication. Support for this work wasmicrowaved for 10 min in the presence of citrate buffer (Gerdes et
provided by National Institutes of Health (NIH) grants R01 CA 31615al., 1992; Hsu et al., 1981). Primary antibodies were applied for 60±90
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